Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	25.11	123.54	98.75
Graham Fair Price	28.27	2.32	1.81
PEG	-89.41	1.01	9.58
Price/Book	-11.49	1.35	1.53
Price/Cash Flow	-59.62	-11.38	28.18
Prices/Earnings	-45.89	64.81	119.76
Price/Sales	-15.24	2.04	2.40
Price/FCF	-59.62	-11.38	28.18
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-42.28	0.05	0.08
Operating Margin	131.59	0.04	0.02
ROA	63.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	63.56
ROIC	< 0.005	< 0.005	181.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.27	-0.12	137.00
Dividends QOQ	0.37	-0.24	-35.49
EBIT QOQ	2.68	1.43	-46.73
EPS QOQ	0.13	0.64	411.11
FCF QOQ	5.43	-3.20	-41.11
Revenue QOQ	0.10	0.05	-54.49
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	53.16	53.80	1.19
Days Sales Outstanding (DSO)	97.48	83.43	-14.41
Inventory Turnover	1.69	1.67	-1.18
Debt/Capitalization	0.67	0.69	3.97
Quick Ratio	0.75	0.76	1.13
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.76	6.78	0.30
Cash	3.73	4.29	14.80
Capex	-0.24	-0.67	-182.71
Free Cash Flow	0.37	-0.81	119.83
Revenue	4.30	4.50	4.73
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.04	1.03	-0.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	45.91	72.34	57.59
Naive Interpretation	Member

06 - Financial Health · Bad

Rating